Literature DB >> 34381221

A persistent look at how tumours evade therapy.

Karen Gomez, Raul Rabadan.   

Abstract

Entities:  

Keywords:  Cancer; Medical research; Metabolism

Mesh：

Year:  2021        PMID： 34381221     DOI： 10.1038/d41586-021-02117-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Ferroptosis Inhibition: Mechanisms and Opportunities.

Authors:  Jose Pedro Friedmann Angeli; Ron Shah; Derek A Pratt; Marcus Conrad
Journal:  Trends Pharmacol Sci       Date:  2017-03-28       Impact factor: 14.819

2.  A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

Authors:  Sreenath V Sharma; Diana Y Lee; Bihua Li; Margaret P Quinlan; Fumiyuki Takahashi; Shyamala Maheswaran; Ultan McDermott; Nancy Azizian; Lee Zou; Michael A Fischbach; Kwok-Kin Wong; Kathleyn Brandstetter; Ben Wittner; Sridhar Ramaswamy; Marie Classon; Jeff Settleman
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

3.  Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.

Authors:  Edward B Garon; Richard J Pietras; Richard S Finn; Naeimeh Kamranpour; Sharon Pitts; Diana C Márquez-Garbán; Amrita J Desai; Judy Dering; Wylie Hosmer; Erika M von Euw; Steven M Dubinett; Dennis J Slamon
Journal:  J Thorac Oncol       Date:  2013-03       Impact factor: 15.609

Review 4.  The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.

Authors:  Ravi Salgia; Prakash Kulkarni
Journal:  Trends Cancer       Date:  2018-02-03

Review 5.  Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.

Authors:  Mohit Kumar Jolly; Prakash Kulkarni; Keith Weninger; John Orban; Herbert Levine
Journal:  Front Oncol       Date:  2018-03-06       Impact factor: 6.244

6.  Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.

Authors:  Matthew J Hangauer; Vasanthi S Viswanathan; Matthew J Ryan; Dhruv Bole; John K Eaton; Alexandre Matov; Jacqueline Galeas; Harshil D Dhruv; Michael E Berens; Stuart L Schreiber; Frank McCormick; Michael T McManus
Journal:  Nature       Date:  2017-11-01       Impact factor: 49.962

7.  Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells.

Authors:  Pan-Yu Chen; Mandar Deepak Muzumdar; Kimberly Judith Dorans; Rebecca Robbins; Arjun Bhutkar; Amanda Del Rosario; Philipp Mertins; Jana Qiao; Anette Claudia Schafer; Frank Gertler; Steven Carr; Tyler Jacks
Journal:  Cancer Res       Date:  2017-12-26       Impact factor: 12.701

8.  Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.

Authors:  Aaron N Hata; Matthew J Niederst; Hannah L Archibald; Maria Gomez-Caraballo; Faria M Siddiqui; Hillary E Mulvey; Yosef E Maruvka; Fei Ji; Hyo-eun C Bhang; Viveksagar Krishnamurthy Radhakrishna; Giulia Siravegna; Haichuan Hu; Sana Raoof; Elizabeth Lockerman; Anuj Kalsy; Dana Lee; Celina L Keating; David A Ruddy; Leah J Damon; Adam S Crystal; Carlotta Costa; Zofia Piotrowska; Alberto Bardelli; Anthony J Iafrate; Ruslan I Sadreyev; Frank Stegmeier; Gad Getz; Lecia V Sequist; Anthony C Faber; Jeffrey A Engelman
Journal:  Nat Med       Date:  2016-02-01       Impact factor: 53.440
  8 in total
  2 in total

Review 1.  Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness.

Authors:  Rinad Mahmoud; Paloma Ordóñez-Morán; Cinzia Allegrucci
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

2.  Addressing Drug Resistance in Cancer: A Team Medicine Approach.

Authors:  Prakash Kulkarni; Atish Mohanty; Supriyo Bhattacharya; Sharad Singhal; Linlin Guo; Sravani Ramisetty; Tamara Mirzapoiazova; Bolot Mambetsariev; Sandeep Mittan; Jyoti Malhotra; Naveen Gupta; Pauline Kim; Razmig Babikian; Swapnil Rajurkar; Shanmuga Subbiah; Tingting Tan; Danny Nguyen; Amartej Merla; Sudarsan V Kollimuttathuillam; Tanyanika Phillips; Peter Baik; Bradford Tan; Pankaj Vashi; Sagun Shrestha; Benjamin Leach; Ruchi Garg; Patricia L Rich; F Marc Stewart; Evan Pisick; Ravi Salgia
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.